AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
AXIM Biotechnologies's price to book ratio was 6.1× on Jan 31, 2022, against 23.0× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 6.1× | −6.5 |
| 2021 | Dec 31, 2021 | 12.7× | −11.0 |
| 2020 | Dec 31, 2020 | 23.7× | +4.6 |
| 2015 | Oct 30, 2015 | 19.1× | – |
See a number that looks wrong?